e-Drug3D

1699

M LOVASTATIN

INN
LOVASTATIN

(is an active metabolite)

cas 75225-51-3

CLASS

CARDIOVASCULAR
HYPOLIPIDEMIC
ANTICHOLESTEREMIC AGENTS
HYDROXYMETHYLGLUTARYL-COA (HMG-COA) REDUCTASE INHIBITORS

ROUTE (list)

ATC code

C10AA02
C10BA01

PK parameters

Tmax 3 HOUR
Cmax 28.1 NANOMOLAR
VD 56.5 LITER (65 KILOGRAM)
Cl 28 LITER / HOUR (65 KILOGRAM)
PPB 95 PERCENT
t1/2 1.4 HOUR

Target

TARGET 3-HYDROXY-3-METHYLGLUTARYL-COENZYME A REDUCTASE

PDB
3HLG (SIMVASTATIN SYNTHASE (LOVD), FROM ASPERGILLUS TERREUS, S5 MUTANT, S76A MUTANT, COMPLEX WITH LOVASTATIN)

Ligand code = LVA (link to the list of PDB complexes)

Download experimental 3D coordinates of LVA with added hydrogens

DrugCentral

3-hydroxy-3-methylglutaryl-coenzyme A reductase UNIPROT P04035 HMGCR

Download SDF file

1-Naphthaleneheptanoic acid, 1,2,6,7,8,8a-hexahydro-beta,delta-dihydroxy-2,6-dimethyl-8-[(2S)-2-methyl-1-oxobutoxy]-, (betaR,deltaR,1S,2S,6R,8S,8aR)-

Formula:
C24H38O6

Calculated chemical properties:

MW 421.54
NB_atoms 30
XLogP 2.38
PSA 92.85
NB_HD 2
NB_HA 6
fsp3 0.75
Lipinski(0=no;1=yes) 1

FDA
-

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL

e-Drug3D

616

LOVASTATIN

INN
LOVASTATIN

(has an active metabolite)

cas 75330-75-5

CLASS

CARDIOVASCULAR
HYPOLIPIDEMIC
ANTICHOLESTEREMIC AGENTS
HYDROXYMETHYLGLUTARYL-COA (HMG-COA) REDUCTASE INHIBITORS

ROUTE (list)

ORAL

NATURAL MOLECULE (link)

ATC code

C10AA02
C10BA01

PK parameters

F 30 PERCENT
Tmax 2 HOUR
Cmax 19.3 NANOMOLAR
PPB 95 PERCENT
t1/2 4.5 HOUR

Solubility

INSOLUBLE IN WATER

Target

TARGET 3-HYDROXY-3-METHYLGLUTARYL-COENZYME A REDUCTASE

PDB
1CQP (CRYSTAL STRUCTURE ANALYSIS OF THE COMPLEX LFA-1 (CD11A) I-DOMAIN, LOVASTATIN AT 2.6 A RESOLUTION)

Ligand code = 803 (link to the list of PDB complexes)

Download experimental 3D coordinates of 803 with added hydrogens

DrugCentral

3-hydroxy-3-methylglutaryl-coenzyme A reductase UNIPROT P04035 HMGCR

Download SDF file

[(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate

Formula:
C24H36O5

Calculated chemical properties:

MW 404.53
NB_atoms 29
XLogP 4.20
PSA 67.515
NB_HD 1
NB_HA 5
fsp3 0.75
Lipinski(0=no;1=yes) 1

FDA
NDA 019643 (label) INN (LOVASTATIN) MEVACOR (MERCK) APPROVAL= AP YEAR= 1987 DISCONTINUED
NDA 021249 (label) INN (LOVASTATIN) ADVICOR (ABBVIE) APPROVAL= AP YEAR= 2001 OBSOLETE
NDA 075300 (pdf not found) INN (LOVASTATIN) LOVASTATIN (CHARTWELL RX) APPROVAL= AP YEAR= 2001
NDA 075451 (pdf not found) INN (LOVASTATIN) LOVASTATIN (AUROBINDO PHARMA USA) APPROVAL= AP YEAR= 2001 DISCONTINUED
NDA 075551 (pdf not found) INN (LOVASTATIN) LOVASTATIN (TEVA) APPROVAL= AP YEAR= 2001
NDA 075636 (pdf not found) INN (LOVASTATIN) LOVASTATIN (EPIC PHARMA LLC) APPROVAL= AP YEAR= 2001
NDA 075828 (pdf not found) INN (LOVASTATIN) LOVASTATIN (ACTAVIS ELIZABETH) APPROVAL= AP YEAR= 2001
NDA 075935 (pdf not found) INN (LOVASTATIN) LOVASTATIN (AUROBINDO PHARMA USA) APPROVAL= AP YEAR= 2001 DISCONTINUED
NDA 021316 (label) INN (LOVASTATIN) ALTOPREV (AZURITY) APPROVAL= AP YEAR= 2002 DISCONTINUED
NDA 075991 (pdf not found) INN (LOVASTATIN) LOVASTATIN (CARLSBAD) APPROVAL= AP YEAR= 2002
NDA 077520 (pdf not found) INN (LOVASTATIN) LOVASTATIN (SUN PHARM INDUSTRIES) APPROVAL= AP YEAR= 2006 DISCONTINUED
NDA 077748 (pdf not found) INN (LOVASTATIN) LOVASTATIN (COREPHARMA) APPROVAL= AP YEAR= 2007
NDA 078296 (pdf not found) INN (LOVASTATIN) LOVASTATIN (LUPIN) APPROVAL= AP YEAR= 2007